Literature DB >> 22197890

Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis.

Necmi Arslan1, Davut Tepe, Eren Taştan, Munir Demirci, Muzaffer Caydere, Huseyin Ustun, Haldun Oguz.   

Abstract

An antibacterial drug, ciprofloxacin, has been reported to modulate the inflammatory and immune responses on monocytes. Our objective is to evaluate the effectiveness of ciprofloxacin in the prevention of myringosclerosis that is created by myringotomy in rats and to compare it with prednisolone. In this study, 24 healthy Sprague-Dawley type rats of age 3-4 months and 250-300 g weight were used. Rats have been divided into three random groups. Topical ciprofloxacin was administered to the rats in the first group and topical prednisolone was administered to the rats in the third group; no medication was applied to their opposite ears and they were determined as control group. Prednisolone was administered to one ear of the rats and ciprofloxacin was administered to their opposite sides in the second group. After bilateral myringotomies the treatments were applied for 20 days as five drops two times a day. Otomicroscopic examination was made on the 10th day and reperforations were made when necessary. Rats were killed on the 21st day and temporal bone dissections were done. When we evaluate in terms of myringosclerosis and tympanic membrane thickness, in the first group, myringosclerosis and thickness have been observed in two of seven ears (28.6%) where ciprofloxacin was administered and in five of the seven ears (71.4%) where no treatment was applied. In the second group where prednisolone and ciprofloxacin were compared, myringosclerosis and thickness have been observed in six of the ten ears (60.0%) where prednisolone was administered and in four of the ten ears (40.0%) where ciprofloxacin was administered. In the third group, myringosclerosis and thickness have been observed in three of seven ears (42.9%) where prednisolone was administered and in four of the seven ears (57.1%) where no treatment was applied. All histopathological evaluations were made by one pathologist in a blinded manner. In our study, the effect of the ciprofloxacin and prednisolone was similar in preventing the experimental myringosclerosis and TM thickness in rats. When compared with the control groups, this preventive effect was more obvious in the ciprofloxacin treatment group than that of prednisolone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197890     DOI: 10.1007/s00405-011-1889-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

1.  The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane.

Authors:  Cengiz Ozcan; Kemal Görür; Leyla Cinel; Derya Umit Talas; Murat Unal; Ismail Cinel
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2002-05-15       Impact factor: 1.675

2.  Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy.

Authors:  C Mattsson; P Stierna; S Hellström
Journal:  Am J Otol       Date:  2000-11

3.  Protection against lipopolysaccharide-induced death by fluoroquinolones.

Authors:  A A Khan; T R Slifer; F G Araujo; Y Suzuki; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 4.  Tympanosclerosis: review of literature and incidence among patients with middle-ear infection.

Authors:  S Asiri; A Hasham; F al Anazy; S Zakzouk; A Banjar
Journal:  J Laryngol Otol       Date:  1999-12       Impact factor: 1.469

5.  Lack of ciprofloxacin ototoxicity after repeated ototopical application.

Authors:  J Claes; P J Govaerts; P H Van de Heyning; S Peeters
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  Topical application of calcium channel blockers to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.

Authors:  Adin Selcuk; Ozgur Akdogan; Ibrahim Ozcan; Seren Gulsen Giray; Huseyin Dere; Candan Ozogul
Journal:  Laryngoscope       Date:  2008-04       Impact factor: 3.325

7.  The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats.

Authors:  Hatice Emir; Zeynep Kizilkaya Kaptan; Erdal Samim; Nuran Sungu; Kursat Ceylan; Huseyin Ustun
Journal:  Otolaryngol Head Neck Surg       Date:  2009-02       Impact factor: 3.497

8.  Analysis of long-term hearing after tympanosclerosis with total/partial stapedectomy and prosthesis used.

Authors:  Hatice Celik; Sevim Aslan Felek; Ahmet Islam; Mustafa A Safak; Necmi Arslan; Hakan Gocmen
Journal:  Acta Otolaryngol       Date:  2008       Impact factor: 1.494

9.  The effect of ciprofloxacin on CD14 and toll-like receptor-4 expression on human monocytes.

Authors:  Goutaro Katsuno; Hideo Kohka Takahashi; Hiromi Iwagaki; Sachi Sugita; Shuji Mori; Shinnya Saito; Tadashi Yoshino; Masahiro Nishibori; Noriaki Tanaka
Journal:  Shock       Date:  2006-03       Impact factor: 3.454

10.  Otomicroscopic and histologic findings of induced myringosclerosis in rats: a critical study of an experimental model.

Authors:  Patrícia F Santos; Mariana C Leal; Cristina Peixoto; Silvio Caldas Neto; Silvania Tavares Paz Rosas
Journal:  Braz J Otorhinolaryngol       Date:  2006-03-31
View more
  2 in total

1.  Predictive factors for the appearance of myringosclerosis after myringotomy with ventilation tube placement: randomized study.

Authors:  Carla Branco; Daniel Monteiro; João Paço
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-09       Impact factor: 2.503

2.  Narrow band imaging endoscopy improves visualization of vessels of the perforated tympanic membrane.

Authors:  Adela Cordero Devesa; Miguel Vaca González; Franklin Mariño-Sánchez; Cecilia Pérez Martínez; Rubén Polo López; María Del Mar Medina González; Ignacio Cobeta Marco
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-06       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.